Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
regulatory
Pharma
Europe's CHMP reverses endorsement of Amgen's Tavneos
The CHMP has now determined that the Advocate study was “conducted in breach of good clinical practice (GCP) principles,” the EU agency said.
Fraiser Kansteiner
Jun 26, 2026 11:07am
ADC plots 17% staff cuts amid Zynlonta safety concerns
Jun 24, 2026 10:19am
Cellares, Ori dominate automated cell therapy production: report
Jun 18, 2026 10:10am
Colorado wins FDA approval to import cheaper drugs from Canada
Jun 17, 2026 10:30am
FDA, MHRA strengthen transatlantic alliance with liaison program
Jun 16, 2026 11:19am
Tavneos patient starts resume in Japan amid safety scrutiny
May 21, 2026 11:38am